Hold Dr Reddy's Lab: IndiaNivesh Securities
Daljeet Kohli, head of research at IndiaNivesh Securities, told NDTV that Dr Reddy's shares were over-owned by the market which led to selloff in the stock. The recent correction in the stock has already factored in the worst-case scenario on account of US FDA warning.
